Biotransformation of Timosaponin BII into Seven Characteristic Metabolites by the Gut Microbiota

Timosaponin BII is one of the most abundant Anemarrhena saponins and is in a phase II clinical trial for the treatment of dementia. However, the pharmacological activity of timosaponin BII does not match its low bioavailability. In this study, we aimed to determine the effects of gut microbiota on t...

Full description

Saved in:
Bibliographic Details
Published in:Molecules
Main Authors: Dong, Guo-Ming, Yu, Hang, Pan, Li-Bin, Ma, Shu-Rong, Xu, Hui, Zhang, Zheng-Wei, Han, Pei, Fu, Jie, Yang, Xin-Yu, Keranmu, Adili, Niu, Hai-Tao, Jiang, Jian-Dong, Wang, Yan
Format: Artigo
Language:Inglês
Published: MDPI 2021
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC8270264/
https://ncbi.nlm.nih.gov/pubmed/34202717
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/molecules26133861
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items